Twilight effects of low doses of ionizing radiation on cellular systems: A bird's eye view on current concepts and research

Medical Oncology

Volumn 27, Issue 2, 2010, Pages 495-509

  Postiglione, Ilaria ^a   Chiaviello, Angela ^a   Palumbo, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Apoptosis; ATM; DNA damage; Hormesis; Ionizing radiation; Mytotic catastrophe; Senescence

Indexed keywords

ATM PROTEIN; ATR PROTEIN; BRCA1 PROTEIN; CHECKPOINT KINASE 2; DNA; HISTONE H2AX; MRE11 PROTEIN; NIBRIN; PROTEIN P53; RAD50 PROTEIN;

APOPTOSIS; BYSTANDER EFFECT; CANCER RISK; CELL AGING; DNA REPAIR; DOUBLE STRANDED DNA BREAK; GENOMIC INSTABILITY; HORMESIS; HUMAN; IONIZING RADIATION; LOW ENERGY RADIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION RESPONSE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BIOMEDICAL RESEARCH; CELL AGING; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; RADIATION INJURIES; RADIATION, IONIZING; SIGNAL TRANSDUCTION;

EID: 77956901194     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9241-9     Document Type: Review

References (163)

1. Grubbé EH. Priority in the therapeutic use of X-rays. Radiology. 1933;21:156-62.
2. Albers-Schonberg H. Uber line bischer unbekannte Wirkukng der Rontgenstnrahlen auf den organismus der tiere. Munch Med Wochenschr. 1903;50:1859-60.
3. Heineke H. Ueber die Einwirkung der Röntgenstrahlen auf Tiere. Munch Med Wochenschr. 1903;50:2090-2.
4. Muller HJ. Artificial transmutation of the gene. Science. 1927;46:84-7. doi:10.1126/science.66.1699.84.
5. Martland HS, Humphries RE. Osteogenic sarcoma in dial painters using luminous paint. Arch Pathol Lab Med. 1929;7:406-17.
6. Leskov KS, Criswell T, Antonio S, Li J, Yang CR, Kinsella TJ, et al. When X-ray-inducible proteins meet DNA double strand break repair. Semin Radiat Oncol. 2001;11:352-7. doi:10.1053/srao.2001.26912.
7. Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis. 2002;23:687-96. doi:10.1093/carcin/23.5.687.
8. Nikiforova MN, Stringer JR, Blough R, Medvedovic M, Fagin JA, Nikiforov YE. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science. 2000;290:138-41. doi:10.1126/science. 290.5489.138.
9. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998;396:643-9. doi:10.1038/25292. (Pubitemid 29003936)
10. Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nature Genet. 2001;27:247-54. doi:10.1038/85798. (Pubitemid 32201842)
11. Vamvakas S, Vock EH, Lutz WK. On the role of DNA doublestrand breaks in toxicity and carcinogenesis. Crit Rev Toxicol. 1997;27:155-74. doi:10.3109/10408449709021617.
12. Richardson C, Jasin M. Frequent chromosomal translocations induced by DNA double-strand breaks. Nature. 2000;405:697-700. doi:10.1038/35015097. (Pubitemid 30428657)
13. Ferguson DO, Alt FW. DNA double strand break repair and chromosomal translocation: lessons from animal models. Oncogene. 2001;20:5572-9. doi:10.1038/sj.onc.1204767. (Pubitemid 32928098)
14. Haimovitz-Friedman A, Khan C, Ehleiter D, Persaud RS, McLoughlin M, Fuks Z, et al. Ionizing radiation acts on cellular membranes in human leukemia cells to generate ceramide and induce apoptosis. J Exp Med. 1994;180:525-35. doi:10.1084/jem.180.2.525. (Pubitemid 24224129)
15. Michael JM, Lavin MF, Watters DJ. Resistance to radiationinduced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling. Cancer Res. 1997;57:3600-5.
16. Zhou BBS, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature. 2000;408:433-9. doi:10.1038/35044005.
17. Bartek J, Falck J, Lukas J. CHK2 kinase-a busy mssenger. Nat Rev Mol Cell Biol. 2001;2:877-86.
18. Shiloh Y. ATM, ATR: Networking cellular responses to DNA damage. CurrOpin Genet Dev. 2001;11:71-7. doi:10.1016/S0959-437X(00)00159-3. (Pubitemid 32119281)
19. Abraham RT. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 2001;15:2177-96. doi:10.1101/gad.914401. (Pubitemid 32843830)
20. Andegeko Y, Moyal L, Mittelman L, Tsarfaty I, Shiloh Y Rotman G. Nuclear retention of ATM at sites of DNA double strand breaks. J Biol Chem. 2001;276:38224-30.
21. Bakkenist CY, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 2003;421:499-506. doi:10.1038/nature01368. (Pubitemid 36168436)
22. Lee JH, Paull TT. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science. 2004;304:93-6.doi:10.1126/science.1091496. (Pubitemid 38451463)
23. Lee JH, Paull TT. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science. 2005;308:551-4. doi:10.1126/science.1108297. (Pubitemid 40570585)
24. Li S, Ting NS, Zheng L, Chen PL, Ziv Y, Shiloh Y, et al. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature. 2000;406:210-5. doi:10.1038/35018134. (Pubitemid 30469007)
25. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER III, Hurov KE, Luo J, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science. 2007;316:1138-9. doi:10.1126/science.1140321. (Pubitemid 46877472)
26. Hirano T. The ABCs of SMC proteins: two-armed ATPases for chromosome condensation, cohesion, and repair. Genes Dev. 2002;16(4):399-414. doi:10.1101/gad.955102. (Pubitemid 34165097)
27. Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops.Oncogene. 2005;24:2899-908. doi:10.1038/sj.onc.1208615.e.
28. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408:307-10. doi:10.1038/35042675.
29. Dalal SN, Schweitzer CM, Gan J, DeCaprio JA. Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site. Mol Cell Biol. 1999;19:4465-79.
30. Hall PA, Kearsey JM, Coates PJ, Norman DG, Warbrick E, Cox LS. Characterisation of the interaction between PCNA and Gadd45. Oncogene. 1995;10:2427-33.
31. 53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science. 1994;266:1376-80.
32. 21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction. Oncogene. 1996;12:595-607.
33. 21/WAF1. Exp Cell Res. 2000;258:92-100. doi:10.1006/excr.2000.4906.
34. Jin S, Antinore MJ, Lung FD, Dong X, Zhao H, Fan F, et al. The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression. J Biol Chem. 2000;275:16602-8.doi:10.1074/jbc.M000284200. (Pubitemid 30398886)
35. 53 Oncogene. 2001;20:1803-15. doi:10.1038/sj.onc.1204252. (Pubitemid 32458690)
36. Bond GL, Hu W, Levine AJ. MDM2 is a central node in the p53 pathway: 12 years and counting. Curr Cancer Drug Targets. 2005; 5:3-8. doi:10.2174/ 1568009053332627. Review.
37. 53-mediated cell cycle arrest at the G2 phase. J Biol Chem. 2000;275:22627-30. doi:10.1074/jbc.C000235200.
38. 53 pathway: what questions remain to be explored? Cell Death Differ. 2006;13:1027-36. doi:10.1038/sj.cdd. 4401910.
39. Bonnet J, Mayonove P, Morris MC. Differential phosphorylation of Cdc25C phosphatase in mitosis. Biochem Biophys Res Commun. 2008;370:483-8. doi:10.1016/j.bbrc.2008.03.117.
40. Dalal SN, Yaffe MB, DeCaprio JA. 14-3-3 family members act coordinately to regulate mitotic progression. Cell Cycle. 2004;3: 672-7.
41. 53 accumulation in response to DNA damage. Proc Natl Acad Sci USA. 1999;96:14973-7. doi:10.1073/pnas.96.26.14973. (Pubitemid 30019749)
42. Fisher D, Méchali M. Sleeping policemen for DNA replication? Nat Cell Biol. 2004;6:576-7. doi:10.1038/ncb0704-576. (Pubitemid 38960911)
43. Furukawa Y, Nishimura N, Furukawa Y, Satoh M, Endo H, Iwase S, et al. Apaf-1 is a mediator of E2F-1-induced apoptosis. J Biol Chem. 2002;277:39760-8. doi:10.1074/jbc.M200805200. (Pubitemid 35190959)
44. 73 in E2F-1-induced apoptosis. Nature. 2000;407:645-8. doi:10.1038/35036614.
45. Khan S, Guevara C, Fujii G, Parry D. p14ARF is a component of the p53 response following ionizing irradiation of normal human fibroblasts. Oncogene. 2004;23:6040-6. doi:10.1038/sj.onc.1207824. (Pubitemid 39178856)
46. Balajee AS, Geard CR. Chromatin-bound PCNA complex formation triggered by DNA damage occurs independent of the ATM gene product in human cells. Nucleic Acids Res. 2001; 29:1341-51. doi:10.1093/nar/29.6.1341.
47. 21Waf1/Cip1 with PCNA. Oncogene. 1995;11: 1931-7
48. Shafman T, Khanna KK, Kedar P, Spring K, Kozlov S, Yen T, et al. Interaction between ATM protein and c-Abl in response to DNA damage. Nature. 1997;387:520-3. doi:10.1038/387520a0. (Pubitemid 27235472)
49. Goldberg Z, Vogt Sionov R, Berger M, Zwang Y, Perets R, Van Etten RA, et al. Tyrosine phosphorylation of MDM2 by c-Abl: implications for p53 regulation. EMBO J. 2002;21:3715-27. doi:10.1093/emboj/cdf384. (Pubitemid 34787045)
50. Sionov RV, Coen S, Goldberg Z, Berger M, Bercovich B, Ben-Neriah Y, et al. c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination. Mol Cell Biol. 2001;21:5869-78. doi:10.1128/MCB.21.17.5869-5878.2001. (Pubitemid 32737804)
51. Jaberaboansari A, Nelson GB, Roti Roti JL, Wheeler KT. Postirradiation alterations of neuronal chromatin structure. Radiat Res. 1998;114:94-104. doi:10.2307/3577147.
52. Malyapa RS, Wright WD, Taylor YC, Roti Roti JL. DNA supercoiling changes and nuclear matrix-associated proteins: possible role in oncogene-mediated radioresistance. Int J Radiat Oncol Biol Phys. 1996;35:963-73. doi:10.1016/0360-3016(96)00211-8. (Pubitemid 26279768)
53. Rogakou ER, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem. 1998;273:5858-68. doi:10.1074/jbc.273.10.5858. (Pubitemid 28124064)
54. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol. 2000;10:886-95. doi:10.1016/S0960-9822(00) 00610-2. (Pubitemid 30647617)
55. Iijima K, Ohara M, Seki R, Tauchi H. Dancing on damaged chromatin: functions of ATM and the RAD50/MRE11/NBS1 complex in cellular responses to DNA damage. J Radiat Res (Tokyo). 2008;49:451-64. doi:10.1269/jrr.08065.
56. Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, Lee A, et al. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat Cell Biol. 2003;5:675-9. doi:10.1038/ncb1004. (Pubitemid 36818091)
57. Burma BP, Murphy CM, Kurimasa A, Chen DJ. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem. 2001;276:42462-7. doi:10.1074/jbc.C100466200. (Pubitemid 37371158)
58. Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM. Quantitative detection of 125IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat Res. 2002;158: 486-92. doi:10.1667/0033-587(2002)158[0486:QDOIID]2.0. CO;2.
59. Rothkamm K, Lobrich M. Evidence for a lack of DNA doublestrand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci USA. 2003;100:5057-62. doi:10.1073/pnas.0830918100. (Pubitemid 36542657)
60. Schultz LB, Chehab NH, Malikzay A, Halazonetis TD. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J Cell Biol. 2000;151: 1381-90. doi:10.1083/jcb.151.7.1381. (Pubitemid 32047588)
61. Rappold I, Iwabuchi K, Date T, Chen J. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J Cell Biol. 2001;153:613-20. doi:10.1083/jcb.153.3.613.
62. Goldberg M, Stucki M, Falck J, D'Amours D, Rahman D, Pappin D, et al. MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature. 2003;421:952-6. doi:10.1038/nature01445. (Pubitemid 36288027)
63. Lou Z, Minter-Dykhouse K, Wu X, Chen J. MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways. Nature. 2003;421:957-61. doi:10.1038/nature01447. (Pubitemid 36288028)
64. Stewart GS, Wang B, Bignell CR, Taylor AM, Elledge SJ. MDC1 is a mediator of the mammalianDNAdamage checkpoint. Nature. 2003;421:961-9666. doi:10.1038/nature01446. (Pubitemid 36288029)
65. Doil C, Mailand N, Bekker-Jensen S, Menard P, Larsen D, Pepperkok R, et al. RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. Cell. 2009;136:435-46. doi:10.1016/j.cell.2008.12.041.
66. Bassing CH, Chua KF, Sekiguchi J, Suh H, Whitlow SR, Fleming JC, et al. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc Natl Acad Sci USA. 2002;99:8173-8. doi:10.1073/pnas. 122228699. (Pubitemid 34651025)
67. Ward IM, Chen J. Histone H2AX is phosphorylated in an TRdependent manner in response to replicational stress. J Biol Chem. 2001;276:47759-62. doi:10.1074/jbc.M009785200.
68. Petrini JH. The Mre11 complex and ATM: collaborating to navigate S phase. Curr Opin Cell Biol. 2000;12:293-6. doi:10.1016/S0955-0674(00)00091-0. (Pubitemid 30265057)
69. Carney JP, Maser RS, Olivares H, Davis EM, Le Beau M, Yater JR, et al. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell. 1998;93:477-86. doi: 10.1016/S0092-8674(00)81175-7. (Pubitemid 28232091)
70. Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, Saar K, et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell. 1998;93:467-76. doi:10.1016/S0092-8674(00) 81174-5. (Pubitemid 28232090)
71. Stewart GS, Maser RS, Stankovic T, Bressan DA, Kaplan MI, Jaspers NGJ, et al. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasialike disorder. Cell. 1999;99:577-87. doi:10.1016/S0092-8674(00)81547-0.
72. Moynahan ME, Chiu JW, Koller BH, Jasin M. Brca1 controls homology-directed DNA repair. Mol Cell. 1999;4:511-8. doi: 10.1016/S1097- 2765(00)80202-6. (Pubitemid 29531131)
73. Snouwaert JN, Gowen LC, Latour AM, Mohn AR, Xiao A, DiBiase L, et al. BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a Brca1 transgene. Oncogene. 1999;18:7900-7. doi: 10.1038/sj.onc.1203334.
74. Morrison C, Sonoda E, Takao N, Shinohara A, Yamamoto K, Takeda S. The controlling role of ATM in homologous recombinational repair of DNA damage. EMBO J. 2000;19:463-71. doi:10.1093/emboj/19.3.463.
75. Barlow C, Liyanage M, Moens PB, Tarsounas M, Nagashima K, Brown K, et al. Atm deficiency results in severe meiotic disruption as early as leptonema of prophase I. Development. 1998; 125:4007-17.
76. Takata M, Sasaki MS, Sonoda E, Morrison C, Hashimoto M, Utsumi H, et al. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J. 1998;17:5497-500. doi:10.1093/emboj/17.18.5497. (Pubitemid 28427063)
77. Essers J, van Steeg H, de Wit J, Swagemakers SMA, Vermeij M, Hoeijmakers JHJ, et al. Homologous and non-homologous recombination differentially affect DNA damage repair in mice. EMBO J. 2000;19:1703-10. doi:10.1093/emboj/19.7.1703.
78. Ron E. Ionizing radiation and cancer risk evidence from epidemiology. Radiat Res. 1998;150:S30-41. doi:10.2307/3579806.
79. Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiat Res. 1996;146:1-27. doi:10.2307/3579391.
80. Thompson DE, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987. Radiat Res. 1994;137:S17-67. doi:10.2307/3578892.
81. Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res. 1994;137:S68-97. doi: 10.2307/3578893.
82. Pierce DA, Preston DL. Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res. 2000;154: 178-86. doi:10.1667/0033-7587(2000) 154[0178:RRCRAL]2.0.CO;2.
83. Schull WJ. Radioepidemiology of the A-bomb survivors. Health Phys. 1996;70:798-803.
84. Chomentowski M, Kellerer AM, Pierce DA. Radiation dose dependencies in the atomic bomb survivor cancer mortality data: a model-free visualization. Radiat Res. 2000;153:289-94. doi: 10.1667/0033-7587(2000)153[0289:RDDITA]2.0. CO;2.
85. United Nations. Sources and effects of ionizing radiation. UNSCEAR 2000 report to the general assembly with scientific annexes. Volume II: Effects. Annex I, Epidemiological evaluation of radiation induced cancer. New York: United Nations, 2000.
86. Pollycove M. The issue of the decade: hormesis. Eur. J Nucl Med. 1995;22:399-401. doi:10.1007/BF00839052.
87. Pollycove M. Low dose linearity: the rule or the exception. BELLE Newsl. 1997;6:13-8.
88. National Council on Radiation Protection. Limitation of exposure to ionizing radiation: report 116. Bethesda, MD: National Council on Radiation Protection; 1993.
89. International Commission on Radiological Protection. Recommendations of the International Commission on Radiological Protection. Ottawa: ICRP Publication; 1990.
90. Scott BR, Di Palma J. Sparsely ionizing diagnostic and background radiations are likely preventing cancer and other genomic-instability-associated diseases. Dose Response. 2006;5: 230-55.
91. Little MP, Muirhead CR. Derivation of low-dose extrapolation factors from analysis of curvature in the cancer incidence dose response in Japanese atomic bomb survivors. Int J Radiat Biol. 2000;76:939-53. doi:10.1080/ 09553000050151646.
92. Trosko JE. Role of low-level ionizing radiation in multi-step carcinogenic process. Health Phys. 1996;70:812-22. doi:10.1097/00004032- 199606000-00005.
93. United Nations. Sources and effects of ionizing radiation. UNSCEAR 2000 Report to the General Assembly with scientific annexes. Volume II: effects. Annex G, Biological effects at low radiation doses. 2000; New York: United Nations.
94. Becker K. Threshold or no threshold, that is the question. Radiat Prot Dosim. 1997;71:3-5.
95. Heidenreich WF, Paretzke HG, Jacob P. No evidence for increased tumor rates below 200 mSv in the atomic bomb survivor data. Radiat Environ Biophys. 1997;36:205-20. doi:10.1007/s004110050073. (Pubitemid 27514937)
96. Hoel DG, Li P. Threshold models in radiation carcinogenesis. Health Phys. 1998;75:241-50. doi:10.1097/00004032-199809000-00002.
97. Health Physics Society. Radiation risk in perspective: position statement of the Health Physics Society. In: Health Physics Society Directory and handbook, 1998-1999.McLean,VA:Health Physics Society; 1998. p. 238-244.
98. Cai L, Liu SZ. Induction of cytogenetic adaptive response of somatic and germ cells in vivo and in vitro by low-dose X-irradiation. Int J Radiat Biol. 1990;58:187-94.
99. Shadley JD. Chromosomal adaptive response in human lymphocytes. Radiat Res. 1994;138:S9-12. doi:10.2307/3578750.
100. Broome EJ, Brown DL, Mitchel RE. Dose responses for adaption to low doses of 60Co gamma rays and 3H beta particles in normal human fibroblasts. Radiat Res. 2002;158:181-6. doi: 10.1667/0033-7587(2002)158[0181:DRFATL]2.0.CO;2.
101. Shadley JD, Afzal V, Wolff S. Characterization of the adaptive response to ionizing radiationinduced by low doses of x-rays to human lymphocytes. Radiat Res. 1987;111:511-7. doi:10.2307/3576936. (Pubitemid 17144564)
102. Wojcik A, Tuschl H. Indications of an adaptive response in C57BL mice pre-exposed in vivo to low doses of ionizing radiation. Mutat Res. 1990;243:67-73. doi:10.1016/0165-7992(90)90125-4.
103. Hooker AM, Bhat M, Day TK, Lane JM, Swinburne SJ, Morley AA, et al. The linear nothreshold model does not hold for low-dose ionizing radiation. Radiat Res. 2004;162:447-52. doi:10.1667/RR3228. (Pubitemid 39388167)
104. Scott BR. Low-dose radiation risk extrapolation fallacy associated with the linear-no-threshold model. BELLE Newsl. 2005; 13: 22-7.
105. Wang GJ, Li X-K, Sakai K, Cai L. Low-dose radiation and its clinical implications: diabetes. BELLE Newsl. 2005;13:12-21.
106. Pollycove M, Feinendegen LE. Biologic response to low doses of ionizing radiation: detriment versus hormesis. Part 2. Dose responses of organisms. J Nucl Med. 2001;42:26N-37N.
107. Feinendegen LE, Pollycove M, Sondhaus CA. Responses to low doses of ionizing radiation in biological systems. Nonlinearity Biol Toxicol Med. 2004;2:143-71. doi:10.1080/15401420490507431.
108. Cohen BL. Cancer risk from low-level radiation. Am J Roentgenol. 2002;179:1137-43.
109. Parsons PA. Hormesis: an adaptive expectation with emphasis onionizing radiation. J Appl Toxicol. 2000;20:103-12. doi:10.1002/(SICI)1099-1263(200003/ 04)20:2<103::AID-JAT639>3.0.CO;2-O. (Pubitemid 30156656)
110. Olivieri G, Bodycote J, Wolff S. Adaptive response of human lymphocytes to low concentrations of radioactive thymidine. Science. 1984;223:594-7. doi:10.1126/science.6695170.
111. Mitchel RE, Jackson JS, McCann RA, Boreham DR. The adaptive response modifies latency for radiation-induced myeloid leukemia in CBA/H mice. Radiat Res. 1999;152:273-9. doi: 10.2307/3580327. (Pubitemid 29413663)
112. Kaiser J. Hormesis. Sipping from a poisoned chalice. Science. 2003;302:376-9. doi:10.1126/science.302.5644.376. (Pubitemid 37296246)
113. Ikushima T, Aritomi H, Morisita J. Radioadaptive response; efficient repair of radiation induced DNA damage in adapted cells. Mutat Res. 1996;358:193-8. doi:10.1016/S0027-5107(96)00120-0. (Pubitemid 26384289)
114. Wolff S. Is radiation all bad? The search for adaptation. Radiat Res. 1992;131:117-23. doi:10.2307/3578431.
115. Feinendegen LE, Muhlensiepen H, Bond VP, Sonhaus CA. Intracellular stimulation of biochemical control mechanisms. Health Phys. 1987;52:663-9. doi:10.1097/00004032-198705000-00020.
116. Djordjevic B. Bystander effect: a concept in need of clarification. Bioessays. 2000;22:286-90. doi:10.1002/(SICI)1521-1878(200003)22:3\286::AID- BIES10[3.0.CO;2-S.
117. Nagasawa H, Little JB. Induction of sister chromatid exchanges by extremely low doses of alpha-particles. Cancer Res. 1992;52: 6394-6.
118. Deshpande A, Goodwin EH, Bailey SM, Marrone BL, Lehnert BE. Alpha-particle-induced sister chromatid exchange in normal human lung fibroblasts: evidence for an extra-nuclear target. Radiat Res. 1996;145:260-7. doi:10.2307/3578980. (Pubitemid 26082619)
119. Azzam EI, de Toledo SM, Little JB. Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha-particle irradiated to non irradiated cells. Proc Natl Acad Sci USA. 2001; 98:473-8. doi:10.1073/pnas.011417098. (Pubitemid 32105066)
120. Zhou H, Suzuki M, Randers-Pehrson G, Vannais D, Chen G, Trosko JE, et al. Radiation risk to low fluences of alpha particles may be greater than we thought. Proc Natl Acad Sci USA. 2001;98:14410-5. doi:10.1073/pnas.251524798. (Pubitemid 33121405)
121. Mothersill C, Seymour RJ, Seymour CB. Bystander effects in repair deficient cell lines. Radiat Res. 2004;161:256-63. doi: 10.1667/RR3136. (Pubitemid 40797067)
122. Mothersill C, Seymour CB. Cell-cell contact during gamma irradiation is not required to induce a bystander effect in normal human keratinocytes: evidence for release during irradiation of a signal controlling survival into the medium. Radiat Res. 1998;149:256-62. doi:10.2307/3579958. (Pubitemid 28104286)
123. Sawant SG, Randers-Pehrson G, Metting NF, Hall EJ. Adaptive response and the bystander effect induced by radiation in C3H 10T(1/2) cells in culture. Radiat Res. 2001;156:177-80. doi: 10.1667/0033-7587(2001)156[0177:ARATBE]2.0. CO;2.
124. Seymour CB, Mothersill C. Delayed expression of lethal mutations and genomic instability in the progeny of human epithelial cells which survived in a bystander killing environment. Radiat Oncol Invest. 1997;5:106-10. doi:10.1002/(SICI)1520-6823(1997)5:3\106::AID-ROI4[3.0.CO;2-1.
125. Wright EG. Inherited and inducible chromosomal instability: a fragile bridge between genome integrity mechanisms and tumourigenesis. J Pathol. 1999;187:19-27. doi:10.1002/(SICI)1096-9896(199901)187:1<19::AID- PATH233>3.0.CO;2-1. (Pubitemid 29009832)
126. Shao C, Furusawa Y, Aoki M, Ando K. Role of gap junctional intercellular communication in radiation-induced bystander effects in human fibroblasts. Radiat Res. 2003;160:318-23. doi: 10.1667/RR3044. (Pubitemid 37052430)
127. Narayanan PK, LaRue KE, Goodwin EH, Lehnert BE. Alpha particles induce the production of interleukin-8 by human cells. Radiat Res. 1999;152:57-63. doi:10.2307/3580049. (Pubitemid 29296246)
128. Hamada N, Matsumoto H, Hara T, Kobayashi Y. Intercellular and intracellular signaling pathways mediating ionizing radiation-induced bystander effects. J Radiat Res (Tokyo). 2007;48: 87-95. doi:10.1269/jrr.06084. (Pubitemid 46535892)
129. Bourguignon MH, Gisone PA, Perez MR, Michelin S, Dubner D, Giorgio MD, et al. Genetic and epigenetic features in radiation sensitivity Part I: cell signalling in radiation response. Eur J Nucl Med Mol Imaging. 2005;32:229-46. doi:10.1007/s00259-004-1730-7. Review. (Pubitemid 40248495)
130. Huang L, Snyder AR, Morgan WF. Radiation-induced genomic instability and its implications for radiation carcinogenesis. Oncogene. 2003;22:5854-948.
131. Lyng FM, Seymour CB, Mothersill C. Initiation of apoptosis in cells exposed to medium from the progeny of irradiated cells: a possible mechanism for bystander induced genomic instability? Radiat Res. 2002;157:365-70. doi:10.1667/0033-7587(2002)157 [0365:IOAICE]2.0.CO;2.
132. Hamada N, Funayama T, Wada S, Sakashita T, Kakizaki T, Ni M, et al. LET-dependent survival of irradiated normal human fibroblasts and their descendents. Radiat Res. 2006;166:24-30. doi:10.1667/RR3579.1. (Pubitemid 44051222)
133. Limoli CL, Giedzinski E, Morgan WF, Swarts SG, Jones GD, Hyun W. Persistent oxidative stress in chromosomally unstable cells. Cancer Res. 2003;63:3107-11.
134. Kronenberg A. Radiation-induced genomic instability. Int J Radiat Biol. 1994;66:603-9. doi:10.1080/09553009414551691.
135. Lewis DA, Mayhugh BM, Qin Y, Trott K, Mendonca MS. Production of delayed death and neoplastic transformation in CGL1 cells by radiation-induced bystander effects. Radiat Res. 2001; 156:251-8. doi:10.1667/0033-7587(2001)156[0251: PODDAN]2.0.CO;2.
136. Moore SR, Marsden S, Macdonald D, Mitchell S, Folkard M, Michael B, et al. Genomic instability in human lymphocytes irradiated with individual charged particles: involvement of tumor necrosis factor alpha in irradiated cells but not bystander cells. Radiat Res. 2005;163:183-90. doi:10.1667/RR3298. (Pubitemid 40170768)
137. Bowler DA, Moore SR, Macdonald DA, Smyth SH, Clapham P, Kadhim MA. Bystander-mediated genomic instability after high LET radiation in murine primary haemopoietic stem cells. Mutat Res. 2006;597:50-61. doi:10.1016/j. mrfmmm.2005.04.025.
138. Clutton SM, Townsend KM, Walker C, Ansell JD, Wright EG. Radiation-induced genomic instability and persisting oxidative stress in primary bone marrow cultures. Carcinogenesis. 1996;17:1633-9. doi:10.1093/carcin/17.8. 1633.
139. Hendry JH, Potten CS. Intestinal cell radiosensitivity: a comparison for cell death assayed by apoptosis or by a loss of clonogenicity. Int J Radiat Biol Relat Stud Phys Chem Med. 1982;42: 621-8. doi:10.1080/09553008214551601.
140. Olive PL, Durand RE. Apoptosis: an indicator of radiosensitivity in vitro? Int J Radiat Biol. 1997;71:695-707. doi:10.1080/0955 30097143707. (Pubitemid 27306025)
141. Aldridge DR, Radford IR. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines. Cancer Res. 1998;58:2817-24.
142. Kyprianou N, King ED, Bradbury D, Rhee J. Bcl-2 overexpression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells. Int J Cancer. 1997;70:341-8. doi:10.1002/(SICI)1097- 0215(19970127)70:3\341::AID-IJC16[3.0.CO;2-I. (Pubitemid 27099605)
143. 53status and the efficacy of cancer therapy in vivo. Science. 1994;266:807-10. doi:10.1126/science.7973635.
144. 21 cip1/waf1 undergo normal development but are defective inG1 checkpoint control. Cell. 1995;82:675-84. doi:10.1016/0092-8674(95)90039-X.
145. Bracey TS, Miller JC, Paraskeva C. Radiation induced apoptosis in human colorectal adenoma and carcinoma cell lines can occur in the absence of wild type p53. Oncogene. 1995;10:2391-6.
146. Guillouf C, Rosselli F, Sjin RT, Moustacchi E, Hofman B, Liebermann DA. Role of amutant p53 protein in apoptosis: characterization of a function independent of transcriptional trans-activation. Int J Oncol. 1998;13:107-14.
147. 53-independent G2/M-associated cell death after g-irradiation. Oncogene. 1997;14:2759-66. doi:10.1038/sj.onc.1201126. (Pubitemid 27313407)
148. Castedo M, Perfettini JL, Roumierh T, Valent A, Raslova H, Yakushijin K, et al. Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene. 2004;23:4362-70. doi:10.1038/sj.onc. 1207572. (Pubitemid 38850415)
149. 2cells following 2.5 to 10 Gy of ionizing radiation. Clin Cancer Res. 2007;13:5501-8.
150. Innocente SA, Abrahamson JL, Cogswell JP, Lee JM. p53 regulates a G2 checkpoint through cyclin B1. Proc Natl Acad Sci USA. 1999;96:2147-52. doi:10.1073/pnas.96.5.2147. (Pubitemid 29117882)
151. 53 function promotes radiation-induced mitotic catastrophe in mouse embryonic fibroblast cells. Cancer Cell Int. 2006;6:11-8. doi:10.1186/1475-2867- 6-11. (Pubitemid 43885037)
152. Luce A, Courtin A, Levalois C, Altmeyer-Morel S, Romeo PH, Chevillard S, et al. Death receptor pathways mediate targeted and non-targeted effects of ionizing radiations in breast cancer cells. Carcinogenesis. 2009;30:432-9. doi:10.1093/carcin/bgp008.
153. Syljuasen RG. Checkpoint adaptation in human cells. Oncogene. 2007;26:5833-9. doi:10.1038/sj.onc.1210402.
154. Campisi J. Cellular senescence as a tumour-suppressor mechanism. Trends Cell Biol. 2001;11:27-31.
155. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. Abiomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995;92:9363-7. doi: 10.1073/pnas.92.20.9363.
156. Hayflick L, Moorhead PS. The serial cultivation of human diploidcell strains. Exp Cell Res. 1961;37:585-621. doi:10.1016/0014-4827(61)90192-6.
157. Weinberg RA. The cat and mouse games that genes, viruses and cells play. Cell. 1997;88:573-5. doi:10.1016/S0092-8674(00) 81897-8.
158. Suzuki M, Boothman DA. Stress-induced premature senescence (SIPS). J Radiat Res. 2008;49:105-12. doi:10.1269/jrr.07081. (Pubitemid 351468637)
159. Chu K, Teele N, Dewey MW, Albright N, Dewey WC. Computerized video time lapse study of cell cycle delay and arrest, mitotic catastrophe, apoptosis and clonogenic survival in irradiated 14-3-3sigma and CDKN1A ( p21) knockout cell lines. Radiat Res. 2004;162:270-86. doi:10.1667/RR3221. (Pubitemid 39295428)
160. Mirzayans R, Scott A, Cameron M, Murray D. Induction of accelerated senescence by gamma radiation in human solid tumour-derived cell lines expressing wild-type TP53. Radiat Res. 2005;163:53-62. doi:10.1667/RR3280. (Pubitemid 40039944)
161. 21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene. 1999;18:4808-18. doi:10.1038/sj.onc.1203078. (Pubitemid 29423564)
162. Podtcheko A, Ohtsuru A, Namba H, Saenko V, Starenki D, Palona I, et al. Inhibition of ABL tyrosine kinase potentiates radiationinduced terminal growth arrest in anaplastic thyroid cancer cells. Radiat Res. 2006;165:35-42. doi:10.1667/RR3466.1. (Pubitemid 43023322)
163. Lehman BD, McCubrey JA, Jeffrerson HS, Paine MS, Chappel WH, Terrian DM. A dominant role for p53 dependent cellular senescence in radiosensitization of human prostate cancer cells. Cell Cycle. 2007;6:595-605.